Affiliations
AffiliationItem in Clipboard
Changes in breast cancer screening rates among 32 community health centers during the COVID-19 pandemicStacey A Fedewa et al. Cancer. 2021.
. 2021 Dec 1;127(23):4512-4515. doi: 10.1002/cncr.33859. Epub 2021 Aug 26. AffiliationItem in Clipboard
AbstractBackground: Breast cancer screening utilization steeply dropped at the start of the coronavirus disease 2019 (COVID-19) pandemic. However, the effects on breast cancer screening in lower income populations are unknown. This study examined changes in breast cancer screening rates (BCSRs) during the pandemic among 32 community health centers (CHCs) that provided health care to lower income populations.
Methods: Secondary data from 32 CHCs participating in an American Cancer Society grant program to increase breast cancer screening services were used. BCSRs were defined as the percentage of women aged 50 to 74 years who had a medical visit in the past 12 months (142,207 in 2018, 142,003 in 2019, and 150,630 in 2020) and received a screening mammogram within the last 27 months. BCSRs in July 2020, July 2019, and June 2018 were compared with screening rate ratios (SRRs) and corresponding 95% confidence intervals (CIs).
Results: BCSRs significantly rose by 18% between 2018 and 2019 (from 45.8% to 53.9%; SRR, 1.18; 95% CI, 1.17-1.18) and then declined by 8% between 2019 and 2020 (from 53.9% to 49.6%; SRR, 0.92; 95% CI, 0.92-0.93). If the 2018-2019 BCSR trends had continued through 2020, 63.3% of women would have been screened in 2020 in contrast to the 49.6% who were; this potentially translated into 47,517 fewer mammograms and 242 missed breast cancer diagnoses in this population.
Conclusions: In this study of 32 CHCs, BCSRs declined by 8% from July 2019 to 2020, and this reversed an 18% improvement between July 2018 and 2019. Declining BCSRs among CHCs during the COVID-19 pandemic call for policies to support and resources to identify women in need of screening.
Keywords: access; breast cancer screening; community health centers; coronavirus disease 2019 (COVID-19); disparities; neoplasm.
© 2021 American Cancer Society.
Conflict of interest statementAll the authors are employed by the American Cancer Society, which receives grants from private and corporate foundations, including foundations associated with companies in the health sector for research outside the submitted work. The salaries for Kristen A. Wehling and Karla Wysocki are partially funded by Pfizer grants for projects outside the scope of this article. Stacey A. Fedewa, Megan M. Cotter, Richard Killewald, and Laura Makaroff are not funded by or key personnel for any of these grants, and their salaries are solely funded through American Cancer Society funds. Fedewa also reports National Cancer Institute honoraria for a Cancer Epidemiology Education in Special Populations talk (August 2019), which were donated to the American Cancer Society, and Makaroff has served on an advisory board for the University of New Mexico project ECHO.
FiguresFigure 1
Observed BCSRs among 32 community…
Figure 1
Observed BCSRs among 32 community health centers: 2018, 2019, and 2020. The observed…
Figure 1Observed BCSRs among 32 community health centers: 2018, 2019, and 2020. The observed BCSRs were defined according to the CMS‐125 measure as the percentage of women aged 50 to 74 years who had a medical visit within the past 12 months and received a screening mammogram within the last 27 months. The observed 2018, 2019, and 2020 BCSRs were as of June 2018, July 2019, and July 2020, respectively. Hypothetical 2020 BCSRs were projected under 2 scenarios: 1) if the 2018‐2019 trend extended through 2020 and 2) if 2019 rates remained level. BCSR indicates breast cancer screening rate.
Figure 2
Observed and projected numbers of…
Figure 2
Observed and projected numbers of women screened among 32 community health centers: 2018,…
Figure 2Observed and projected numbers of women screened among 32 community health centers: 2018, 2019, and 2020. Observed numbers of breast cancer screenings were computed as of July 2018, 2019, and 2020. The number of breast cancer screenings was projected under 2 scenarios: 1) if the 2018‐2019 trend extended through 2020 and (2) if 2019 rates remained level.
Similar articlesJohnson KJ, O'Connell CP, Waken RJ, Barnes JM. Johnson KJ, et al. PLoS One. 2024 May 20;19(5):e0303280. doi: 10.1371/journal.pone.0303280. eCollection 2024. PLoS One. 2024. PMID: 38768115 Free PMC article.
Sprague BL, Lowry KP, Miglioretti DL, Alsheik N, Bowles EJA, Tosteson ANA, Rauscher G, Herschorn SD, Lee JM, Trentham-Dietz A, Weaver DL, Stout NK, Kerlikowske K. Sprague BL, et al. J Natl Cancer Inst. 2021 Sep 4;113(9):1161-1167. doi: 10.1093/jnci/djab045. J Natl Cancer Inst. 2021. PMID: 33778894 Free PMC article.
Nyante SJ, Benefield TS, Kuzmiak CM, Earnhardt K, Pritchard M, Henderson LM. Nyante SJ, et al. Cancer. 2021 Jun 15;127(12):2111-2121. doi: 10.1002/cncr.33460. Epub 2021 Feb 26. Cancer. 2021. PMID: 33635541 Free PMC article.
Tsapatsaris A, Babagbemi K, Reichman MB. Tsapatsaris A, et al. Clin Imaging. 2022 Feb;82:224-227. doi: 10.1016/j.clinimag.2021.11.025. Epub 2021 Dec 7. Clin Imaging. 2022. PMID: 34896935 Free PMC article. Review.
DeSantis C, Siegel R, Bandi P, Jemal A. DeSantis C, et al. CA Cancer J Clin. 2011 Nov-Dec;61(6):409-18. doi: 10.3322/caac.20134. Epub 2011 Oct 3. CA Cancer J Clin. 2011. PMID: 21969133 Review.
Chen N, Cheng D, Sodipo MO, Barnard ME, DuPre NC, Tamimi RM, Warner ET. Chen N, et al. Breast Cancer Res Treat. 2023 Nov;202(2):335-343. doi: 10.1007/s10549-023-07083-y. Epub 2023 Aug 25. Breast Cancer Res Treat. 2023. PMID: 37624552 Free PMC article.
Blavin FE, Smith LB, Dubay L, Basurto L. Blavin FE, et al. Cancer Med. 2023 Aug;12(15):16548-16557. doi: 10.1002/cam4.6246. Epub 2023 Jun 22. Cancer Med. 2023. PMID: 37347148 Free PMC article.
Badal K, Staib J, Tice JA, Kim MO, Eklund M, Wilson L, Dacosta Byfield S, Catlett K, Maffey L, Soonavala R, Shieh Y, Esserman LJ. Badal K, et al. BMJ Open. 2025 Feb 17;15(2):e089428. doi: 10.1136/bmjopen-2024-089428. BMJ Open. 2025. PMID: 39961709 Free PMC article.
Fefferman M, Kuchta K, Wang CH, Nicholson K, Kopkash K, Pesce C, Poli E, Smith TW, Yao K. Fefferman M, et al. Cancer Med. 2024 Jan;13(1):e6874. doi: 10.1002/cam4.6874. Epub 2023 Dec 22. Cancer Med. 2024. PMID: 38140789 Free PMC article.
Khan MMM, Munir MM, Woldesenbet S, Endo Y, Khalil M, Tsilimigras D, Harzman A, Huang E, Kalady M, Pawlik TM. Khan MMM, et al. Ann Surg Oncol. 2024 May;31(5):3222-3232. doi: 10.1245/s10434-024-15029-x. Epub 2024 Feb 15. Ann Surg Oncol. 2024. PMID: 38361094 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3